PHILADELPHIA, Jan. 9, 2012 /PRNewswire/ -- Aberdeen Israel
Fund, Inc. (the "Fund") (NYSE AMEX: ISL), a closed-end equity fund,
announced today its performance data and portfolio composition as
of November 30, 2011.
The Fund's total returns for various periods through
November 30, 2011 are provided
below. (All figures are based on distributions reinvested at
the dividend reinvestment price and are stated
net-of-fees):
|
Period
|
NAV
Total Return %
|
Market
Price Total Return %
|
|
|
Cumulative
|
Annualized
|
Cumulative
|
Annualized
|
|
Since
inception
(October
1992)
|
251.9
|
6.8
|
196.7
|
5.9
|
|
10-years
|
118.3
|
8.1
|
129.9
|
8.7
|
|
5-years
|
20.5
|
3.8
|
12.3
|
2.3
|
|
3-years
|
79.5
|
21.5
|
109.5
|
28.0
|
|
1-year
|
-10.6
|
-14.6
|
On November 30, 2011, the Fund's
net assets amounted to US$68.1
million and the Fund's NAV per share was $15.93.
As of November 30, 2011, the
portfolio was invested as follows:
|
Portfolio Composition
|
Percent
of
Net
Assets
|
|
Financials
|
24.5
|
|
Consumer, Non-Cyclical
|
17.3
|
|
Technology
|
15.7
|
|
Basic Materials
|
13.1
|
|
Communications
|
8.9
|
|
Health Care
|
8.5
|
|
Industrials
|
4.1
|
|
Other
|
3.3
|
|
Consumer, Cyclical
|
3.0
|
|
Cash
|
1.6
|
The Fund's ten largest equity holdings as of November 30, 2011, representing 71.9% of net
assets, were:
|
Stock
|
Percent
of
Net
Assets
|
|
Check
Point Software Technologies Ltd.
|
13.8
|
|
Perrigo
Company
|
9.9
|
|
United
Mizrahi Bank Ltd.
|
8.7
|
|
Teva
Pharmaceutical Industries Ltd.
|
8.4
|
|
Israel
Chemicals Limited
|
8.3
|
|
Bezeq
Israeli Telecomunication Corporation Ltd.
|
7.2
|
|
Bank Leumi
Le-Israel
|
4.5
|
|
Super
Sol
|
4.0
|
|
Frutarom
Industries Ltd.
|
3.7
|
|
Azrieli
Group
|
3.4
|
Important Information
Aberdeen Asset Management Inc. has prepared this report based on
information sources believed to be accurate and reliable.
However, the figures are unaudited and neither the Fund, Aberdeen
Asset Management Investment Services Limited (the Investment
Adviser), nor any other person guarantees their accuracy.
Investors should seek their own professional advice and should
consider the investment objectives, risks, charges and expenses
before acting on this information. Aberdeen is a U.S. registered
service mark of Aberdeen Asset Management PLC.
Closed-end funds have a one-time initial public offering and
then are subsequently traded on the secondary market through one of
the stock exchanges. The investment return and principal value will
fluctuate so that an investor's shares may be worth more or less
than the original cost. Shares of closed-end funds may trade above
(a premium) or below (a discount) the net asset value (NAV) of the
fund's portfolio. There is no assurance that a fund will achieve
its investment objective. Past performance does not guarantee
future results.
Total return figures with distributions reinvested at the
dividend reinvestment price are stated net-of-fees and represents
past performance. Past performance is not indicative of
future results, current performance may be higher or lower.
Holdings are subject to change and are provided for informational
purposes only and should not be deemed as a recommendation to buy
or sell the securities shown. Inception date October 29, 1992.
If you wish to receive this information electronically, please
contact: InvestorRelations@aberdeen-asset.com
SOURCE Aberdeen Israel Fund, Inc.